Senate Appropriations Committee Clears President’s Full MDUFMA Request
This article was originally published in The Gray Sheet
Executive Summary
The Medical Device Manufacturers Association is appealing to AdvaMed to ponder substantive changes to MDUFMA at the larger group's board meeting in Washington, D.C. Sept. 22-23
You may also be interested in...
User Fees To Rise 16% As FDA Backs Historical Data Over Industry Estimates
FDA is declining to adopt an industry proposal that would have halved the agency's projected 18% PMA user fee hike for fiscal 2005
IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific antibody versus Janssen’s teclistamab and also maintains that the setback for Gilead’s magrolimab hasn’t eclipsed prospects for its bispecific antibody.
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and reports progress on initiatives aimed at improving technology adoption. A schedule of ambitious future timelines has also been published.